Search For "monoclonal"
GVRP and Yurogen Biosystems Announce Partnership to Enhance Biologics Drug
Updated : 2 months, 2 weeks ago IST
Hyderabad (Telangana) [India], February 20: GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, a global life sciences company specialising in custom biologics development. The collaboration is aimed at expanding access for Indian biotech
Read More
"Highly infectious, fatal": AIIMS Bilaspur president says no vaccine avail
Updated : 4 months, 1 week ago IST
"Nipah virus is highly infectious and fatal. Patients either develop symptoms of encephalitis or severe respiratory disease. The mortality rate ranges between 40 and 75 per cent, which is very high," Dr Arora told ANI.
Read More
Intas and Henlius receive positive CHMP opinion for HETRONIFLY® (HANS
Updated : 1 year, 8 months ago IST
Ahmedabad (Gujarat) [India], September 25: Intas Pharmaceuticals Limited ("Intas") has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of HETRONIFLY® (serplulimab, approve
Read More
Health Experts Endorse Government's 2030 Rabies Eradication Plan in IHW Co
Updated : 1 year, 11 months ago IST
New Delhi [India], July 8: On the 17th annual observance of World Zoonoses Day, a virtual conference organized by the IHW Council under the 'VIRAM - Full Stop on Rabies' campaign, brought together eminent health experts to address the urgent challenge of eliminating rabies by 2030. The event
Read More
EMA approves Biocon Biologics' new monoclonal antibodies facility, renews
Updated : 1 year, 11 months ago IST
According to a press release, this facility, designed to produce multiple drug substances, will now commence the production of biosimilar Bevacizumab, enhancing the company's capacity to meet the growing demand for biologics across European markets.
Read More
Zumutor Biologics Announces Dosing of First Patient with ZM008, a First-in
Updated : 1 year, 11 months ago IST
Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting innate immunological pathways, today announced that the first patient was do
Read More
Do you know obesity is linked to detection of blood cancer precursor? Stud
Updated : 8 months ago IST
A new study found that obese people are more likely to develop monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that usually arises before multiple myeloma.
Read More
Obesity connected to detection of blood cancer precursor: Study
Updated : 8 months ago IST
According to a recent study, there is a higher likelihood of monoclonal gammopathy of unknown significance (MGUS), a benign blood disorder that frequently occurs before multiple myeloma, among obese individuals.
Read More
Nipah virus: India to source 20 more doses of monoclonal antibody from Aus
Updated : 2 years, 8 months ago IST
ICMR Director General Dr Rajiv Bahl said that no one has been so far been administered the medicine in India, further highlighting that the medicine needs to be given during the early stage of the infection.
Read More
Nipah virus: One more case confirmed in Kerala; Total tally 6, active case
Updated : 2 years, 8 months ago IST
With this the total tally of Nipah virus infections from the virus in Kerala has been recorded at six, including two deaths.
Read More
Zumutor Biologics Inc announces FDA clearance of IND application of ZM008,
Updated : 2 years, 9 months ago IST
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
Read More
Study sheds light on immunotherapy treatment for ALS
Updated : 8 months ago IST
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
Read More